Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126244221 | 12624422 | 1 | I | 20160722 | 20160805 | 20160805 | EXP | ZA-LUPIN PHARMACEUTICALS INC.-2016-03398 | LUPIN | MURUNGA E, ANDERSSON M, RENSBURG C. AUTOIMMUNE HEPATITIS: A MANIFESTATION OF IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME IN HIV INFECTED PATIENTS?. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2016;1-5. | 31.00 | YR | F | Y | 0.00000 | 20160805 | MD | ZA | ZA |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126244221 | 12624422 | 1 | SS | Tenofovir | TENOFOVIR | 1 | Unknown | Y | UNKNOWN | 0 | |||||||||
126244221 | 12624422 | 2 | PS | LAMIVUDINE. | LAMIVUDINE | 1 | Unknown | Y | UNKNOWN | 205217 | |||||||||
126244221 | 12624422 | 3 | SS | NEVIRAPINE. | NEVIRAPINE | 1 | Unknown | Y | UNKNOWN | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126244221 | 12624422 | 1 | HIV infection |
126244221 | 12624422 | 2 | HIV infection |
126244221 | 12624422 | 3 | HIV infection |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126244221 | 12624422 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126244221 | 12624422 | Autoimmune hepatitis |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |